Dr. Luo earned her MD and PhD degrees from Duke University, then completed an internship and residency in internal medicine at the New York-Presbyterian Weill Cornell Medical Center, followed by a clinical fellowship in Nephrology and a research fellowship in Transplant Nephrology at that institution.  Luo’s research primarily focuses on the induction and mechanisms of transplantation tolerance, using innovative donor-specific negative vaccination strategies to target the host machineries involved in clearance of cellular apoptotic debris in an immunotolerogenic manner.  She also investigates the engineering of biosynthetic platforms with tolerogenic signals for potentially “off-the-shelf” tolerance treatment options for transplant recipients.  Luo has been elected to serve on the Pancreas Transplantation Committee of the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS), the Education Committee of the Transplantation Society (TTS), and the Executive Committee of the American Society of Transplantation (AST) Community of Basic Scientists (CoBS).  Luo has received numerous awards, including the Kidney and Urology Foundation of American Research Fellowship Award, the American Society of Transplantation Council’s Fellowship Award, the American Federation for Medical Research Centocor Scholar Award, and the Basic Science Investigator Award of the American Society of Transplantation. In 2013, she was elected to the American Society of Clinical Investigation.